Clinical Trial Update: Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating celecoxib to prevent hand-foot syndrome caused by capecitabine in metastatic breast or colorectal cancer was terminated. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer, Colorectal Cancer | Phase 3 | Status: TERMINATED | Results posted: 2015-12-24